Home › Funds › Carnegie Investment Counsel › CME
Carnegie Investment Counsel position in CME
CME GROUP INC · Financials
Carnegie Investment Counsel reported holding 152,288 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$37.9M, representing 0.76% of its reported portfolio and ranking #28 among its reported holdings. Carnegie Investment Counsel has disclosed CME holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Carnegie Investment Counsel's CME position evolved
Carnegie Investment Counsel first disclosed a stake in CME in Q1 2024 at 9,482 shares (US$2.0M). The position peaked in Q1 2026 at 162,478 shares, worth US$45.7M. Across 11 filings, Carnegie Investment Counsel increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 152,288 shares valued at US$37.9M — a reduction of -7,393 shares quarter over quarter.. Notable position changes include a 1102% increase in Q1 2025 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 9.48K | $2.04M | New |
| Q2 2024 | 9.56K | $1.88M | Add |
| Q3 2024 | 10.51K | $2.32M | Add |
| Q4 2024 | 11.35K | $2.64M | Add |
| Q1 2025 | 136.44K | $36.04M | Add |
| Q2 2025 | 148.78K | $41.01M | Add |
| Q3 2025 | 155.72K | $42.08M | Add |
| Q4 2025 | 157.20K | $42.93M | Add |
| Q1 2026 | 162.48K | $45.66M | Add |
| Q2 2026 | 159.68K | $33.55M | Reduce |
| Q3 2026 | 152.29K | $37.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CME and 13F data
CME (CME GROUP INC) is a Financials company. 25 other funds we track also report a position in CME — the largest reported positions include Sanders Capital, LLC (US$1.33B), RAYMOND JAMES FINANCIAL INC (US$1.08B), Fidelity International (FIL) (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CME
- Sanders Capital, LLC 5.06M sh · $1.33B · Q3 2026
- RAYMOND JAMES FINANCIAL INC 4.14M sh · $1.08B · Q3 2026
- Fidelity International (FIL) 3.96M sh · $1.04B · Q3 2026
- Alphabet Inc. 3.48M sh · $912.74M · Q3 2026
- Mitsubishi UFJ Asset Management Co., Ltd. 2.85M sh · $746.64M · Q3 2026
- ROYAL BANK OF CANADA 3.28M sh · $725.35M · Q2 2026
- Capital Wealth Planning, LLC 3.22M sh · $711.67M · Q2 2026
More on Carnegie Investment Counsel
FAQ
How long has Carnegie Investment Counsel held CME?
Carnegie Investment Counsel has disclosed CME holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Carnegie Investment Counsel's current position in CME?
As of Q3 2026, Carnegie Investment Counsel holds 152.29K shares of CME (CME GROUP INC), valued at $37.86M, representing 0.76% of its reported portfolio and ranking #28.
Has Carnegie Investment Counsel been buying or selling CME?
In the latest 13F filing (Q3 2026), Carnegie Investment Counsel reduced its position in CME. The position peaked in Q1 2026 at 162.48K shares.
Which other funds hold CME?
Other major institutional holders of CME include Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, Fidelity International (FIL), among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.